BBB

BIOMAXIMA

No trades
See on Supercharts
Market capitalization
‪64.15 M‬PLN
‪3.05 M‬
Beta (1Y)
0.19

About BIOMAXIMA

CEO
Lukasz Maria Urban
Headquarters
Lublin
Founded
1997
ISIN
PLBIOMX00015
FIGI
BBG000BBN6S3
Biomaxima SA operates in the field of biotechnology and laboratory diagnostics. It offers diagnostic reagents to study biochemical parameters of blood and other body fluids including analyzers, rapid diagnostic tests for the detection of infectious diseases, tumor markers, markers of myocardial infarction, and drugs. The firm also produces systems for analyzing urine, hematology reagents, and blood analyzers. The company was founded in 1997 and is headquartered in Lublin, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BMX is 15.15 PLN — it has decreased by 0.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange BIOMAXIMA stocks are traded under the ticker BMX.
BMX stock is 4.10% volatile and has beta coefficient of 0.19. Check out the list of the most volatile stocks — is BIOMAXIMA there?
BIOMAXIMA revenue for the last quarter amounts to ‪11.00 M‬ PLN despite the estimated figure of ‪14.60 M‬ PLN. In the next quarter revenue is expected to reach ‪10.70 M‬ PLN.
Yes, you can track BIOMAXIMA financials in yearly and quarterly reports right on TradingView.
BMX stock has fallen by 3.50% compared to the previous week, the month change is a 21.39% rise, over the last year BIOMAXIMA has showed a 42.07% decrease.
BMX net income for the last quarter is ‪−366.00 K‬ PLN, while the quarter before that showed ‪384.00 K‬ PLN of net income which accounts for −195.31% change. Track more BIOMAXIMA financial stats to get the full picture.
Today BIOMAXIMA has the market capitalization of ‪61.20 M‬, it has increased by 4.29% over the last week.
Yes, BMX dividends are paid annually. The last dividend per share was 0.50 PLN. As of today, Dividend Yield (TTM)% is 3.28%. Tracking BIOMAXIMA dividends might help you take more informed decisions.
Like other stocks, BMX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMAXIMA stock right from TradingView charts — choose your broker and connect to your account.
BMX reached its all-time high on Jul 29, 2020 with the price of 61.00 PLN, and its all-time low was 2.90 PLN and was reached on Dec 2, 2014.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMAXIMA technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMAXIMA stock shows the sell signal. See more of BIOMAXIMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOMAXIMA future price: according to them, BMX price has a max estimate of 26.40 PLN and a min estimate of 26.40 PLN. Read a more detailed BIOMAXIMA forecast: see what analysts think of BIOMAXIMA and suggest that you do with its stocks.